WallStreetZenWallStreetZen

AnalystsJeffrey La Rosa
Jeffrey La Rosa's Stock Forecasts

Analyst Ranking
Top 46%
#2106 out of 4565 analysts
Average Return
+19.71%
Win Rate
100%2 out of 2
Risk vs Reward
Poor
Good

Jeffrey La Rosa's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Pyxis Oncology IncPYXS
+37.38%$3.13$4.30
2024-01-22 -
2024-04-25
Buy
Merck & Co IncMRK
+2.03%$100.77$102.82
2022-10-27 -
2023-10-27
Buy

Jeffrey La Rosa Analyst Color

Get additional color on Jeffrey La Rosa's coverage of popular stocks

Jeffrey La Rosa's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Pyxis Oncology IncPYXS
1Buy$12.00+179.07%Initiates Coverage On
3 months ago
Merck & Co IncMRK
1Buy$112.00N/AMaintains
a year ago
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.